Invesco Dorsey Wright Healthcare Momentum ETF PTH
59.90 USD +2.50 (+4.36%)
Nov 9, 2026, 2:57 PM EST
58.06 Day range 60.08
46.09 52-week range 64.10
- YTD
- +20.52%
- 1 year
- +26.91%
- Market cap
- 133.94M
- EPS (ttm)
- 1.52
- P/E ratio
- 39.40
- YTD return
- +20.52%
- 1-year return
- +26.91%
- Volume
- 11.32K
- Avg volume
- 38.43K
- Open
- 58.06
- Previous close
- 57.40
- Day's range
- 58.06 – 60.08
- 52-week range
- 46.09 – 64.10
6M +8.17 (+15.82%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 44.93
- 200-day average
- 44.07
About Invesco Dorsey Wright Healthcare Momentum ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics.
News
Moderna Advances Ebola Vaccine Into Human Testing 
Judge Hands Natera 30% Ongoing Royalty In MRD Patent Battle 
FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer 
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs 
US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget 
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' 
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst 
Is Reddit Favorite BioNano Genomics About To Nosedive? 
3 Health Care ETFs Where Components Are Enduring Downgrades 
3 ETFs To Play Gilead's $21B Immunomedics Takeover
Your note
Sign in to keep a note on PTH — it syncs with the Stock Master app.